Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

Conference Coverage

Will Shapiro, Flatiron Health
Conference Coverage
The Future of AI in Cancer Care
10/08/2023

Featuring Will Shapiro

Featuring Will Shapiro
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of Data Insights Engineering at Flatiron Health, shares insights into recent developments in the use of AI in cancer care and what advances are anticipated in this area.
Will Shapiro, vice president of...
10/08/2023
Journal of Clinical Pathways
Conference Coverage
The Impact of Health Care Industry Consolidation on Cancer Care and Partnerships
10/08/2023

Emry Lloyd

Emry Lloyd
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny, Harlan Levine, and Todd Schonherz discuss the challenges and benefits of health care industry consolidation.
Ronald Barkley, Barbara McAneny,...
10/08/2023
Journal of Clinical Pathways
News
CPC & CBEx Keynote Session: How Do We Define Value-Based Oncology Care?
10/07/2023

Brandon Twyford

Brandon Twyford
The keynote session from the 2023 CPC & CBEx Annual Conference featured Harlan Levine, MD, City of Hope, in a thought-provoking presentation on what "value" in value-based care really means, and how to achieve a truly patient-centered model...
The keynote session from the 2023 CPC & CBEx Annual Conference featured Harlan Levine, MD, City of Hope, in a thought-provoking presentation on what "value" in value-based care really means, and how to achieve a truly patient-centered model...
The keynote session from the...
10/07/2023
Journal of Clinical Pathways

Advertisement

Conference Coverage
Using Clinical Pathways to Reduce Delays in Time to Treatment
10/07/2023

Grace Taylor

Grace Taylor
At CPC & CBEx 2023, Dennis R. Holmes, MD, discusses the impacts of delays in time to treatment for patients and how physician can use clinical pathways to provide more efficient treatment.
At CPC & CBEx 2023, Dennis R. Holmes, MD, discusses the impacts of delays in time to treatment for patients and how physician can use clinical pathways to provide more efficient treatment.
At CPC & CBEx 2023, Dennis R....
10/07/2023
Journal of Clinical Pathways
News
How Clinical Pathways Can be Used For HER2-Positive Breast Cancer Therapies
10/07/2023

Emry Lloyd

Emry Lloyd
At CPC & CBEx 2023, Sayeh Lavasani, MD, discussed the different ways clinical pathways can be followed for HER2-positive breast cancer therapies.
At CPC & CBEx 2023, Sayeh Lavasani, MD, discussed the different ways clinical pathways can be followed for HER2-positive breast cancer therapies.
At CPC & CBEx 2023, Sayeh...
10/07/2023
Journal of Clinical Pathways
News
CPC & CBEx 2023: Critical Trends in the Oncology Landscape
10/06/2023

Brandon Twyford

Brandon Twyford
To open Friday’s schedule of sessions at the Clinical Pathways Congress & Cancer Care Business Exchange, Lee Blansett, MBA, Executive Vice President for HMP Market Access Insights, discussed critical trends in today’s oncology...
To open Friday’s schedule of sessions at the Clinical Pathways Congress & Cancer Care Business Exchange, Lee Blansett, MBA, Executive Vice President for HMP Market Access Insights, discussed critical trends in today’s oncology...
To open Friday’s schedule of...
10/06/2023
Cancer Care Business Exchange

Advertisement

James Hamrick, MD
Conference Coverage
AI in Cancer Care: Separating Fact from Fiction
10/06/2023

Featuring James Hamrick, MD

Featuring James Hamrick, MD
James Hamrick, MD, discusses his presentation "AI in Cancer Care: Separating Fact from Fiction" at the 2023 Clinical Pathways Congress + Cancer Care Business Exchange meeting.
James Hamrick, MD, discusses his presentation "AI in Cancer Care: Separating Fact from Fiction" at the 2023 Clinical Pathways Congress + Cancer Care Business Exchange meeting.
James Hamrick, MD, discusses his...
10/06/2023
Journal of Clinical Pathways
Barbara McAneny, MD
Conference Coverage
CPC & CBEx Session Preview: Updates from Washington, Healthcare Industry Consolidation, and Cancer Care at Home
10/03/2023

Featuring Barbara McAneny, MD

Featuring Barbara McAneny, MD
CPC & CBEx faculty member Barbara McAneny, MD, gives a preview of her three featured sessions from the conference, including key points on health care industry consolidation, legislative updates, and important considerations for delivering...
CPC & CBEx faculty member Barbara McAneny, MD, gives a preview of her three featured sessions from the conference, including key points on health care industry consolidation, legislative updates, and important considerations for delivering...
CPC & CBEx faculty member...
10/03/2023
Journal of Clinical Pathways
Conference Coverage
Use of Pharmacogenomic Testing to Predict Bruton’s Tyrosine Kinase Inhibitor Treatment Intolerance
08/09/2023

Emry Lloyd

Emry Lloyd
Researchers conducted a study to determine whether cytochrome P450 polymorphisms can contribute to treatment intolerance in patients receiving Bruton’s tyrosine kinase inhibitors.
Researchers conducted a study to determine whether cytochrome P450 polymorphisms can contribute to treatment intolerance in patients receiving Bruton’s tyrosine kinase inhibitors.
Researchers conducted a study to...
08/09/2023
Journal of Clinical Pathways

Advertisement

Aaron P. Mitchell, MD, MPH
Videos
Study Examines the Association Between Oncologists’ Receipt of Pharmaceutical Industry Payments and Use of Nonrecommended/Low-Value Treatments
07/20/2023

Featuring Aaron P. Mitchell, MD

Featuring Aaron P. Mitchell, MD ...
Aaron P. Mitchell, MD, MPH, discusses his research on the association of pharmaceutical industry payments to oncologists and their increased use of nonrecommended and/or low-value treatment methods.
Aaron P. Mitchell, MD, MPH, discusses his research on the association of pharmaceutical industry payments to oncologists and their increased use of nonrecommended and/or low-value treatment methods.
Aaron P. Mitchell, MD, MPH,...
07/20/2023
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP May/June 2024 Issue

Current Issue

June 2024
Volume 10
Issue 3
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
Special Report
Clinical Pathways Updates in Multiple Myeloma: New and Expected Treatments for Refractory and Resistant Multiple Myeloma
01/14/2021
01/14/2021
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use